COMMENTARY: The Sinatra Doctrine Confronts a Global Consensus
A photo-collage. Credit: Peter Costantini.By Peter CostantiniSEATTLE, Oct 23 2020 (IPS) By late September, the COVID-19 pandemic in the United States had claimed 200,000 lives. That’s equivalent to a slightly higher toll than the 418,500 United States deaths in World War II, adjusted for relative population and duration. [See note below.]
With four percent of the world’s population, the U.S. has suffered 20 percent of global COVID-19 deaths.
Tragically, most of these deaths need never have happened. They were caused primarily by the public-health equivalent of friendly fire: massive malpractice and deception by the Don...
Source: IPS Inter Press Service - Health - October 23, 2020 Category: International Medicine & Public Health Authors: Peter Costantini Tags: Global Geopolitics Global Governance Headlines Health TerraViva United Nations Source Type: news
What Developing Countries Can Teach Us About How To Respond To a Pandemic
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post What Developing Countries Can Teach Us About How To Respond To a Pandemic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 16, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health TerraViva United Nations Source Type: news
Scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses
In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the Institut Pasteur and CNRS, studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 and MERS-CoV in order to identify commonly hijacked cellular pathways and detect promising targets for broad coronavirus inhibition. In addition, (Source: World Pharma News)
Source: World Pharma News - October 16, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
The mental health impact of pandemics for front line health care staff
(University of East Anglia) New research shows the impact that pandemics have on the mental health of front-line health care staff.Researchers investigated how treating patients in past pandemics such as SARS and MERS affected the mental health of front-line staff.They found that over a third experienced anxiety or depression, almost a quarter experienced PTSD.The team hope that their work will help highlight the impact that the Covid-19 pandemic could be having on the mental health of doctors and nurses worldwide. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 16, 2020 Category: Infectious Diseases Source Type: news
Aetion statement on UCSF-led study to inform drug development for COVID-19, future pandemics
(Aetion) Aetion co-authored a study published today inScience, which examined lethal coronaviruses SARS-CoV-2, SARS-CoV-1, and MERS-CoV to identify molecular characteristics of potential treatments. The study, which was led by the Quantitative Biosciences Institute at UCSF and involved nearly 200 researchers from leading institutions, applied a novel approach to evaluate molecular hypotheses by analyzing real-world data from COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news
Global study identifies common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses
(Georgia State University) There are common vulnerabilities among three lethal coronaviruses, SARS-CoV-2, SARS-CoV-1 and MERS-CoV, such as frequently hijacked cellular pathways, that could lead to promising targets for broad coronavirus inhibition, according to a study by an international research team that includes scientists from the Institute for Biomedical Sciences at Georgia State University. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news
Team of international scientists identify common vulnerabilities across coronaviruses
(University of California - San Francisco) In a study published online inScience, today, an international team of almost 200 researchers from 14 leading institutions in six countries studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 and MERS-CoV in order to identify commonly hijacked cellular pathways and detect promising targets for broad coronavirus inhibition. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news
Repurposing drugs for a pan-coronavirus treatment
(European Molecular Biology Laboratory - European Bioinformatics Institute) The study identifies drug targets common to all three coronaviruses (SARS-CoV-2, SARS-CoV-1, and MERS-CoV) and potential drugs that could be repurposed as COVID-19 treatments. The researchers suggest that repurposed pan-coronavirus therapeutics may offer a rapid treatment response against future emerging coronavirus strains (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news
'Brain fog' following COVID-19 recovery may indicate PTSD
(University of California - Los Angeles Health Sciences) A new report suggests that lingering " brain fog " and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), an effect observed in past human coronavirus outbreaks such as SARS and MERS. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 6, 2020 Category: Infectious Diseases Source Type: news
Persistence of SARS-CoV-2 in Aerosol Suspensions Persistence of SARS-CoV-2 in Aerosol Suspensions
How does the aerosol efficiency of SARS-CoV-2 compare with that of SARS-CoV and MERS-CoV?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
What are the effects of quarantine for close contacts of people with confirmed COVID19?, Cochrane Clinical Answers
Reviewers conducted a rapid review of the evidence on quarantine for close contacts of people with confirmed COVID ‐19 (plus isolation of the infected individual) and identified one observational study conducted in Singapore, along with eight modeling studies based on data collected from China, Singapore, the UK, the cruise ship Diamond Princess, or generic populations. Studies reported that quarantine for clo se contacts decreased the incidence of COVID‐19, mortality, and resource use (such as hospitalization and numbers of doctors and nurses needed in intensive care units). Reviewers rated the certainty of all eviden...
Source: Current Awareness Service for Health (CASH) - September 24, 2020 Category: Consumer Health News Source Type: news
Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the par...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news
Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the par...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news
Progress toward antiviral treatments for COVID-19
COVID-19 is caused by a virus known as SARS-CoV-2, which is similar in structure to two other viruses that have caused recent outbreaks: SARS-CoV, which caused an outbreak of SARS in 2003, and MERS-CoV, the cause of a 2012 outbreak of Middle East Respiratory Syndrome. (Source: World Pharma News)
Source: World Pharma News - September 15, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Progress toward antiviral treatments for COVID-19
(American Institute of Physics) COVID-19 is caused by the virus SARS-CoV-2, which is structurally similar to the viruses that cause SARS-CoV and MERS-CoV. In The Journal of Chemical Physics, scientists report molecular-level investigations of these viruses, providing a possible pathway to antiviral drugs to fight the diseases. They looked at a viral protein that plays a role in the virus's ability to replicate and in defeating the host's immune system, making it an attractive target for potential drug treatments. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 15, 2020 Category: Infectious Diseases Source Type: news
